Clinical Trial Update: A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reporting a Phase 1/2 study of QLS31905 in combination chemotherapy as first-line treatment for advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• QLS31905

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN